Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 150 results found. Search for [ Zydus coronavirus vaccine ]

Results 1 to 21 of 150
BusinessToday.In
New Delhi, October 27, 2020
Sunil Mittal-led Bharti Airtel on Monday said it has entered the fast-growing cloud communications market with the launch of Airtel IQ today; Johnson & Johnson has said that the first batches of its COVID-19 vaccine could be available as soon as January; World Health Organisation (WHO) chief Tedros Adhanom Ghebreyesus on Sunday warned vaccine nationalism would only prolong the pandemic. Watch this and more on News Blast.Also Read: Ant Group IPO: 5 interesting facts about the world's biggest public offering


Vivek Punj
New Delhi, October 27, 2020
Johnson & Johnson says first batches of COVID-19 vaccine may be available as soon as JanuaryAmid ongoing coronavirus pandemic, Johnson & Johnson has said that the first batches of its COVID-19 vaccine could be available as soon as in January. The first batches of its shots are expected to be available for emergency use by starting 2021, Ruxandra Draghia-Akli, the company's head of public health research and development, said in a presentation at the World Health Summit.Bharti Airtel...


PB Jayakumar & Joe C Mathew
October 26, 2020
Zydus Cadila's COVID-19 candidate vaccine ZyCov-D, which is currently undergoing second phase of clinical trials in India, is likely to enter Phase III final stage of clinical trials by December 2020


BusinessToday.In
October 26, 2020
Coronavirus vaccine: The pharma company plans to start late-stage trials of the vaccine candidate next month. Over 26,000 candidates would be monitored for the vaccine candidate's efficacy


BusinessToday.In
October 23, 2020
Covaxin, the coronavirus vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), is expected to be at least 60 per cent effective


BusinessToday.In
October 22, 2020
Covaxin, the COVID-19 vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR), has received the approval of Drugs Controller General of India (DCGI's) Expert Committee to start the final phase of trials


BusinessToday.In
October 19, 2020
India Stock Market Highlights Today: ONGC, followed by NTPC, HDFC, Axis Bank, ICICI Bank, PowerGrid and Nestle India were among the top gainer on Sensex pack. On the other hand, TCS, Tech Mahindra, Infosys and Sun Pharma were among the laggards.


BusinessToday.In
October 19, 2020
Stocks to watch today on October 19: HDFC Bank, Tata Communications, Avenue Supermarts, Bajaj Consumer, RIL among others are the top stocks to watch out for in Monday's trading session


BusinessToday.In
October 17, 2020
The shots planned for the initial phase would include a booster dose as well. The list comprises four categories of beneficiaries including frontline workers, healthcare professionals, people above 50, and people with comorbidities


BusinessToday.In
October 16, 2020
Ivermectin, a drug used to treat lice and other parasites, has shown some promising results against coronavirus, claims a specialist from Melbourne


BusinessToday.In
October 16, 2020
The WHO said that the Solidarity trial looked at the effects of these treatments on overall mortality, initiation of ventilation, and duration of hospital stay in hospitalised patients


BusinessToday.In
October 14, 2020
Coronavirus vaccine update: Bharat Biotech is ready to start Covaxin's Phase 3 trail to test the vaccine on about 28,500 volunteers


BusinessToday.In
October 14, 2020
Coronavirus vaccine update: Biopharma company Epygen Biotech with operations in Mumbai and Dubai is planning to launch an affordable COVID-19 vaccine with an aim to roll out 500 million doses within six months


BusinessToday.In
October 12, 2020
Coronavirus vaccine: There are four US-based companies whose vaccine candidates have moved into the crucial phase-3 development phase. This includes--Pfizer, Moderna, Johnson & Johnson, and Novavax


BusinessToday.In
October 4, 2020
COVID-19 vaccine update: The Centre is deliberating allowing companies to secure vaccine doses directly and early on to ensure that there is no disruption of key economic activities


BusinessToday.In
October 3, 2020
COVID-19 vaccine: A principal investigator from a trial site in Maharashtra said that they are expecting to finish enrolling the participants within the next two months after which they will be monitored for the vaccine's efficacy


BusinessToday.In
October 2, 2020
Coronavirus cases in India: The active patients' tally in India stands at 9,42,217; around 53,52,078 patients have recovered and 99,773 have succumbed to the deadly virus so far


BusinessToday.In
October 1, 2020
Coronavirus vaccine update: In India, there are three COVID-19 vaccines under human trials--Bharat Biotech's COVAXIN, Oxford's COVDSHIELD, and Zydus Cadila's ZyCoV-D. Serum Institute has already begun a phase-3 trial of Oxford vaccine candidates at 17 sites


BusinessToday.In
September 30, 2020
COVID-19 vaccine being developed by AstraZeneca-Oxford University, Novavax, Moderna, Pfizer Inc and Johnson & Johnson are already in an advanced stage of testing


BusinessToday.In
September 28, 2020
The government is going to assess efficacy data of all concerned companies (working on COVID-19 vaccines) before inking a purchase contract with them and will buy vaccines at least for essential workers


PAGES 1 OF 8  12345